Biotechnology News CEFDINIR Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-5 out of 5 found

Current Search: cefdinir: 5

Indian generic companies may tread Ranbaxy path
India's leading pharma firms such as Ranbaxy, Dr Reddy's (DRL), Sun Pharma and Lupin are all involved in various patent litigation's with global drug biggies like Pfizer, Eli Lilly, Glaxo, Wyeth, Novartis and AstraZeneca.

Last year alone,...

TradingMarkets: Jun 20 2008 9:03PM
Matching: cefdinir

Find similar documents

Generic cos may tread Ranbaxy path
MUMBAI: Ranbaxy Laboratories' patent settlement with Pfizer may set a trend, with more Indian generic firms likely to go for out-of-court settlements with their innovator counterparts.

India's leading pharma firms such as Ranbaxy, Dr Reddy...

Economictimes: Jun 18 2008 8:11PM
Matching: cefdinir

Find similar documents

Indian generic companies may tread Ranbaxy path
MUMBAI: Ranbaxy Laboratories' patent settlement with Pfizer may set a trend, with more Indian generic firms likely to go for out-of-court settlements with their innovator counterparts.

Indias leading pharma firms such as Ranbaxy, Dr Reddys...

Economictimes: Jun 18 2008 7:35PM
Matching: cefdinir

Find similar documents

Orchid Chemicals net dips by 35% in Q4, dividend at 30%
Orchid Chemicals & Pharmaceuticals, a Rs 1,300 crore pharma giant from Chennai, has suffered setback during the fourth quarter ended March 2008.

Its net profit declined by 34.7 per cent to Rs 15.85 crore from Rs 24.27 crore in the...

PharmaBiz: May 29 2008 3:46PM
Matching: cefdinir

Find similar documents

Lupin consolidated net dips by 32% in Q4, dividend at 100%
Lupin Ltd, the fifth largest pharmaceutical company in India with net sales over Rs 2900 crore, has suffered setback during the fourth quarter ended March 2008.

It's consolidated net profit declined by 32.1 per cent to Rs 95.87 crore from...

PharmaBiz: May 14 2008 11:36AM
Matching: cefdinir

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.